GCG and type 2 diabetes mellitus: For some authors, the effect of tirzepatide on GIP receptors remains unclear, as the drug favors their downregulation, acting more like a functional antagonist [116], as evidenced by the greater reduction in plasma glucagon with tirzepatide in T2D patients compared to dulaglutide [117].